メディア&マーケティング

バイオサイトジェンがイナリサーチと提携し日本でのプレゼンス向上を目指す

2020年11月30日、中国北京のBeijing Biocytogen Co., Ltd.(以下「バイオサイトジェン」)は、日本市場での事業拡大のために長野県のイナリサーチ株式会社(以下「イナ」)と同日をもって商業代理店契約を締結したと発表しました。

もっと読む
Webinar 丨In Vivo vs. In Vitro Therapeutic Antibody Discovery

Biocytogen’s antibody discovery expert, Dr. Lei Chen will speak on current antibody discovery platforms, focusing in on a fully human antibody mouse (RenMab™ Mouse), as well as on how to expedite the screening of antibody candidates, from early discovery

もっと読む
Biocytogen at the ESMO 2018 Annual Meeting

Biocytogen at the at the ESMO 2018 annual meeting, which will take place in Munich, Germany from between 19-23 October 2018

もっと読む
PEGS Europe 2019

Biocytogen has recently developed RenMab™ Mouse, a fully human antibody mouse with its entire variable regions replaced by human Ig heavy chain and light chain.

もっと読む
バイオサイトジェン-佑和医薬が共同で新型コロナウイルス(COVID-19)完全ヒト抗体の「カクテル」療法の開発への推進を加速

バイオサイトジェンでは自社による研究開発の完全ヒト抗体RenMabマウス及び特色ある新薬研究開発プラットフォームを用いて新型コロナウイルス完全ヒト抗体の研究開発事業を全速力で展開しています

もっと読む
Biocytogen’s President & CEO, Dr. Yuelei Shen, Speaks at Harvard China Forum at Harvard Universi

Biocytogen’s President & CEO, Dr. Yuelei Shen, WuXi AppTec’s US CEO, Dr. Richard Connell, and BlackRock’s healthscience fund manager, Dr. Erin (Hongying) Xie, were invited to speak at the conference’s Pharmaceuticals Panel by the panel moderator Ms.

もっと読む
Biocytogen’s RenMab™ Mouse is Featured on Fiercebiotech

FierceBiotech and its family of publications provide end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval—and all the seed funding, venture capital, licensing deals, IPOs and M&A that h

もっと読む
Biocytogen Closes $79M Series D Funding

On August 2019, Beijing Biocytogen Co., Ltd. (“Biocytogen”) announced the closing of its Series D funding of $79M (RMB 543M).

もっと読む
Experts in Genetically Engineered Animal Development and Maintenance

もっと読む
Symposium: Future of Biologic Drug Discovery and Development

Free to attend, lunch and light dinner will be provided. Join Biocytogen to learn more about the cutting-edge technologies and latest research in biologic drug.

もっと読む
Back to top